
What We're Reading: Second US Coronavirus Death; Expensive Extended-Release Drugs; Third ACA Decision
The second US Coronavirus death was reported in EvergreenHealth hospital in Kirkland, Washington; extended-release drugs were shown to cost almost $14 billion more than twice-a-day medications over a 5-year study; the Supreme Court plans to hear the third challenge to the Affordable Care Act in October.
Second US Coronavirus Death in Washington State
Yesterday, health authorities in King County, Washington, announced that 1 of the 6 individuals infected with coronavirus in a nursing facility in the Seattle suburb of Kirkland had died at EvergreenHealth hospital, with 3 more in critical condition, according to
Extended-Release Drugs Linked With Significantly Higher Costs
According to a study published in
Supreme Court to Hear Third Challenge to the ACA
After turning down a motion by the House of Representatives and Democratic-led states this term to review the legality of the Affordable Care Act (ACA), the Supreme Court will hear a third challenge to the ACA, potentially in October, with a decision coming before the November election.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.